None of the patients other than the child with PPB were offered genetic diagnostics, albeit for DICER1 or KRAS mutations.<h4>Conclusion</h4>The study underscores the heterogeneity in age and clinical presentation at the time of CLM diagnosis, highlighting the importance of an individualized and tailored approach to management. Here, KRAS is linked to pleuropulmonary blastoma.